Contact Information
Who We Are
Although Genentech's products are covered by most government and private insurance, Genentech has established the Genentech Access to Care Foundation (GATCF) for each of its marketed products to make them available to qualified uninsured or under-insured patients in the United States. The program was recently expanded to provide free drugs to eligible patients who have private insurance and have met or exceeded their lifetime maximum benefits.
All of Genentech's products are covered by the Genentech Access to Care Foundation, except for Pulmozyme (dornase alfa), which is covered by the Genentech Endowment for Cystic Fibrosis. For consideration of eligibility for resources from the Genentech Access to Care Foundation, the patient must not be eligible for public or private insurance reimbursement and must meet income restrictions.
Visit the website for detailed information about GATCF and how to apply for help.
.